Stephen Nimer, MD | Authors


Dr. Stephen Nimer on MSI2 as a Requirement for Maintaining Activated MDS Stem Cells

December 06, 2015

Stephen Nimer, MD, leukemia and lymphoma treatment specialist, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, discusses results of a study which examined Musashi2 as a requirement for maintaining activated myelodysplastic syndrome (MDS) cells.